Roundup Settlement 2026 Hearing: Why the $7.25 Billion Deal Just Got Pushed to August 19

Why the Roundup Settlement Hearing Just Got Pushed to August 19

Bayer’s bid to close the book on Roundup litigation hit a scheduling snag this week. A Missouri state court judge set a new August 19, 2026 hearing date to review the company’s proposed $7.25 billion Roundup settlement, delaying a fairness hearing that had originally been scheduled for July 9. The six-week postponement isn’t a sign the deal is unraveling. It’s a byproduct of a jurisdictional tug-of-war over whether a settlement this large, covering tens of thousands of cancer claims nationwide, belongs in front of a state judge in St. Louis or should be routed through federal court instead.

St. Louis Circuit Judge Timothy Boyer, who has presided over several Roundup trials and granted preliminary approval to the settlement back in March, had signaled he might delay the hearing while that jurisdictional question got sorted out. The timing lined up with a much bigger event: on June 25, 2026, the U.S. Supreme Court handed Bayer a significant win in a separate but closely related case, Monsanto Co. v. Durnell, reshaping the legal landscape the settlement was built on just two weeks before the original hearing date.

Bayer’s Monsanto unit was quick to downplay the delay. In a statement, the company said the six-week shift in the Roundup settlement 2026 hearing date would not materially affect the approval timeline and reaffirmed that the settlement is backed by most plaintiffs’ firms involved in the litigation.

Settlement Amount	Up to $7.25 billion, paid out over 17–21 years
Court	22nd Judicial Circuit Court, St. Louis, Missouri (Judge Timothy Boyer)
Original Hearing Date	July 9, 2026 (fairness/final approval hearing)
New Hearing Date	August 19, 2026
Reason for Delay	Jurisdictional dispute over federal vs. state court review, following the Supreme Court’s June 25, 2026 Durnell ruling
Claims Covered	Non-Hodgkin lymphoma (NHL) linked to Roundup/glyphosate exposure
Estimated Payouts	$10,000 to $165,000+ per qualifying claim (up to roughly $198,000 with adjustments)
Opt-Out Deadline	June 4, 2026 (closed)
Pending Claims Nationwide	Approximately 65,000 in state and federal courts
Class Counsel Fees	$675 million, included within the $7.25 billion total

Inside the $7.25 Billion Bayer Glyphosate Settlement Fund

The Roundup settlement fund is designed to resolve both current and future claims from people who developed non-Hodgkin lymphoma after using Roundup, the glyphosate-based weedkiller Bayer acquired when it bought Monsanto in 2018. Filed in St. Louis Circuit Court on February 17, 2026, the deal received preliminary approval on March 4, 2026, and structures payments over an unusually long horizon: up to 21 years, with roughly $1 billion front-loaded into the first year to get money moving quickly for claimants with active diagnoses.

Bayer has framed the fund as the capstone of a broader containment strategy that also included the June 25 Supreme Court ruling. Company leadership has said the class settlement and the litigation strategy at the Supreme Court were always meant to work together, not as a backup plan for each other.

How the Payout Tiers Work

Individual awards under the Roundup settlement fund currently range from about $10,000 to $165,000 or more, depending on the severity of the diagnosis, age at diagnosis, treatment history, and other case-specific factors. With adjustments for certain claim categories, some estimates put the higher end closer to $198,000. Claimants won’t see a single flat number; the fund uses a tiered compensation grid similar to what’s been used in other mass tort settlements, weighing medical documentation and exposure history rather than paying everyone the same amount.

Roughly $675 million of the total fund is allocated to class counsel fees, led by attorney Christopher Seeger, with that amount built into the $7.25 billion figure rather than paid on top of it. Once the settlement receives final approval, class members with a qualifying NHL diagnosis will have 180 days to register for benefits, and claims must be filed within 180 days after any appeals are resolved.

The Supreme Court’s Durnell Ruling Changed the Leverage Overnight

It’s hard to talk about the Roundup settlement 2026 hearing without talking about Monsanto Co. v. Durnell. On June 25, 2026, the Supreme Court ruled 7-2 in Bayer’s favor, holding that the Federal Insecticide, Fungicide, and Rodenticide Act, or FIFRA, expressly preempts state-law failure-to-warn claims when the EPA has already evaluated the relevant health risk and approved a label without a warning. Justice Brett Kavanaugh wrote the majority opinion, joined by Chief Justice John Roberts and Justices Samuel Alito, Sonia Sotomayor, Elena Kagan, Amy Coney Barrett, and Clarence Thomas.

What Monsanto v. Durnell Actually Decided

The case traced back to John Durnell, a Missouri gardener who used Roundup for about 20 years while spraying weeds for his neighborhood association and developed non-Hodgkin lymphoma. A jury awarded him $1.25 million in 2023 after finding Monsanto failed to warn him about cancer risk, and the Missouri Court of Appeals upheld that verdict. The Supreme Court reversed, reasoning that because the EPA has repeatedly evaluated glyphosate and consistently found it unlikely to cause cancer, Missouri couldn’t require a warning label the federal government never mandated. That, the Court said, would create the kind of state-by-state inconsistency FIFRA’s preemption clause was written to prevent.

Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch, arguing that the majority misread FIFRA and left Durnell, along with thousands of similarly situated plaintiffs, without any real remedy.

What Durnell Does Not Wipe Out

The ruling is significant, but it isn’t a total shield for Bayer. Legal analysts have been clear that Durnell applies specifically to failure-to-warn theories tied to labeling. Claims built on other legal theories, including design defect, manufacturing defect, and misleading advertising, are not automatically foreclosed and may remain viable paths for plaintiffs who choose not to participate in the class settlement. The same day it decided Durnell, the Court also remanded several other pending Roundup cases back to lower courts so they could be reconsidered in light of the new ruling, which will likely keep design-defect and related claims moving through the system even as failure-to-warn claims get dismissed.

Who’s Objecting to the Roundup Class Settlement

Not every plaintiffs’ firm is on board. Attorneys from Keller Postman and Frazer PLC filed a formal challenge on May 21, 2026, on behalf of ten non-Hodgkin lymphoma claimants who object to the settlement’s terms, and their concerns are expected to be a central topic at the rescheduled fairness hearing. Separately, attorneys from 14 other law firms representing close to 20,000 potential class members raised procedural concerns earlier in the process, even though most ultimately did not opt out by the June 4 deadline.

There’s also friction outside the Missouri courtroom. U.S. District Judge Vince Chhabria, who oversees the separate federal Roundup multidistrict litigation, publicly described the proposed deal as “filthy” in commentary issued in May 2026. Chhabria does not preside over the state-court class settlement, so his remarks don’t carry direct legal weight over Judge Boyer’s courtroom, but they underscore that the settlement still has vocal critics among judges and plaintiffs’ attorneys who think the compensation structure shortchanges claimants relative to what juries have awarded in individual trials.

What Happens at the August 19 Fairness Hearing

At the rescheduled hearing, Judge Boyer will weigh objections, evaluate whether the settlement is fair, reasonable, and adequate for the class as a whole, and decide whether to grant final approval. Because the opt-out and objection deadlines already passed on June 4, 2026, the pool of participating claimants is largely locked in; the hearing is now primarily about resolving objector challenges like the one from Keller Postman and Frazer PLC, not about reopening the class definition.

Bayer has previously said it needs participation to be “very close” to 100% of the eligible class for the settlement’s economics to work, since the company retains the right to terminate the agreement if opt-outs run too high. Given how few claimants opted out by the June 4 deadline, that threshold appears to have been cleared, which is one reason Bayer expressed confidence that the six-week delay would not derail approval.

Timeline: Roundup Settlement 2026, Month by Month

• February 17, 2026 — Bayer and class counsel file the $7.25 billion settlement motion in St. Louis Circuit Court.
• March 4, 2026 — Judge Boyer grants preliminary approval; a 90-day opt-out and objection window opens.
• April 27, 2026 — The Supreme Court hears oral argument in Monsanto Co. v. Durnell.
• May 21, 2026 — Keller Postman and Frazer PLC file an objector challenge on behalf of ten NHL claimants.
• June 4, 2026 — Opt-out and objection deadline closes.
• June 25, 2026 — The Supreme Court rules 7-2 for Monsanto in Durnell on FIFRA preemption.
• June 30, 2026 — Judge Boyer resets the fairness hearing from July 9 to August 19, 2026, amid the federal-versus-state jurisdiction dispute.
• August 19, 2026 — Rescheduled final fairness hearing; Boyer decides whether the settlement receives final approval.

What This Means If You’re a Claimant

If you already registered as part of the Roundup class and didn’t opt out by June 4, you’re bound by the class settlement structure regardless of the outcome of individual objections. The practical next step is final approval at the August 19 hearing, after which the 180-day registration and claims-filing clock begins. If you’re weighing whether to pursue an individual claim outside the class, the Durnell decision narrows failure-to-warn arguments specifically, but design-defect and manufacturing claims remain an open lane, and an attorney experienced in Roundup litigation can help evaluate which category your case falls into.

For claimants still deciding how to proceed, it’s worth remembering that mass tort settlements of this size rarely move in a straight line. Hearing dates shift, objectors file motions, and appellate rulings like Durnell can reshape leverage on both sides in the span of a single news cycle. Staying close to updates from the court and from your own attorney matters more than any single headline about the settlement fund’s total dollar figure.

Frequently Asked Questions

When is the new Roundup settlement 2026 hearing date?
The fairness hearing was moved from July 9, 2026 to August 19, 2026, in the 22nd Judicial Circuit Court in St. Louis, Missouri, before Judge Timothy Boyer.

Why was the Roundup settlement hearing delayed?
The delay stems from a dispute over whether the settlement should be reviewed in state court or federal court, a question that gained new weight after the Supreme Court’s June 25, 2026 ruling in Monsanto Co. v. Durnell. Bayer says the six-week delay will not materially affect the approval process.

How much is the Bayer Roundup settlement worth?
The settlement is valued at up to $7.25 billion, paid out over 17 to 21 years, with about $1 billion front-loaded in the first year.

How much money will I get from the Roundup settlement fund?
Individual payouts are expected to range from roughly $10,000 to $165,000 or more per qualifying non-Hodgkin lymphoma diagnosis, with some adjusted awards reaching close to $198,000. The exact amount depends on diagnosis severity, treatment history, and documentation.

What did the Supreme Court decide in Monsanto v. Durnell?
On June 25, 2026, the Supreme Court ruled 7-2 that FIFRA preempts state-law failure-to-warn claims against Roundup when the EPA has already evaluated the cancer risk and approved a label without a warning. The ruling does not eliminate design-defect or manufacturing-defect claims.

Can I still opt out of the Roundup class settlement?
No. The opt-out and objection deadline was June 4, 2026, and has already passed. Class members who did not opt out by that date are bound by the settlement structure.

Who is objecting to the Roundup settlement?
Keller Postman and Frazer PLC filed a formal objection on May 21, 2026, on behalf of ten non-Hodgkin lymphoma claimants. Federal MDL judge Vince Chhabria has also publicly criticized the settlement, though he does not preside over the state-court class.

How many Roundup lawsuits are still pending?
Bayer faces approximately 65,000 claims in U.S. state and federal courts from people alleging Roundup exposure caused non-Hodgkin lymphoma or other cancers.